Stefanie Mesch

Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i> -[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile

Stefan Werner, Stefanie Mesch, R.C. Hillig et al. · Journal of Medicinal Chemistry · 2019 · 55 citations · Full text

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis

Thomas T. Tapmeier, Nilüfer Rahmioğlu, Jianghai Lin et al. · Science Translational Medicine · 2021 · 46 citations

From a Library of MAG Antagonists to Nanomolar CD22 Ligands

Stefanie Mesch, Katrin Lemme, Matthias Wittwer et al. · ChemMedChem · 2011 · 42 citations

Mag Antagonists, Glycobiology, Molecular Biology +17

Synthesis of sialic acid derivatives as ligands for the myelin-associated glycoprotein (MAG)

Sachin V. Shelke, Gan‐Pan Gao, Stefanie Mesch et al. · Bioorganic & Medicinal Chemistry · 2007 · 39 citations

Myelin-associated Glycoprotein, Biochemistry, Glycobiology +3

Low Molecular Weight Antagonists of the Myelin-Associated Glycoprotein: Synthesis, Docking, and Biological Evaluation

Stefanie Mesch, Delia Moser, Daniel S. Strasser et al. · Journal of Medicinal Chemistry · 2010 · 33 citations · Full text

Myelin-associated Glycoprotein, Neuroregeneration, Biochemistry +15